Imatinib mesylate has also been found to inhibit the cellular growth of NB both in vitro and in vivo, and the inhibition of cellular growth is correlated with the decrease in expression of platelet‐derived growth factor receptor alpha (PDGFR), c‐kit, and VEGFR.186. This evidence concerns the gene KDR and neuroblastoma.